LOADING

Type to search

Author: Ben Adams

takeda-doesn’t-have-to-divest-shire-pipeline-med-as-no-one-wants-it,-so-it-tosses-it-out
amid-pandemic,-labcorp’s-cro-unit-covance-pens-decentralized-trials-pact-with-medable
covid-19-vaccine-leaders-talk-up-the-need-for-partners,-potential-for-a-working-vax-by-october
after-passing-safety-hurdle,-orpheris-kick-starts-covid-19-cytokine-storm-efficacy-test
protalix,-chiesi-edge-close-to-potential-fabry-disease-approval
another-alexion-alum-joins-rallybio-ranks
trial-disruption-‘likely-to-continue,’-but-130-trials-are-now-back-up-and-running:-report
gilead-pens-$2b-arcus-pact-for-immuno-oncology-targets-of-the-past-and-future
parexel,-microsoft-azure-launch-covid-19-real-world-data-platform
the-money-keeps-coming-for-eli-lilly-covid-19-partner-abcellera-with-$105m-round